Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis

Gronberg C, Rattik S, Kunz M, Thoung Trinh-Minh , TRAN MANH C, Zhou X, Skoog P, Liberg D, Distler J (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 3227-3228

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Meik Kunz Lehrstuhl für Medizinische Informatik CUONG TRAN MANH Department of Medicine 3 – Rheumatology and Immunology Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

Cantargia AB SE Sweden (SE)

How to cite

APA:

Gronberg, C., Rattik, S., Kunz, M., Thoung Trinh-Minh, ., TRAN MANH, C., Zhou, X.,... Distler, J. (2022). Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY (pp. 3227-3228). HOBOKEN: WILEY.

MLA:

Gronberg, Caitriona, et al. "Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2022. 3227-3228.

BibTeX: Download